534 related articles for article (PubMed ID: 18505800)
1. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
[TBL] [Abstract][Full Text] [Related]
2. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
3. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
Watson L; Vonk JM; Löfdahl CG; Pride NB; Pauwels RA; Laitinen LA; Schouten JP; Postma DS;
Respir Med; 2006 Apr; 100(4):746-53. PubMed ID: 16199147
[TBL] [Abstract][Full Text] [Related]
4. Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort.
Mannino DM; Davis KJ; Kiri VA
Respir Med; 2009 Feb; 103(2):224-9. PubMed ID: 18945605
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease.
Albers M; Schermer T; Heijdra Y; Molema J; Akkermans R; van Weel C
Thorax; 2008 Mar; 63(3):201-7. PubMed ID: 17905823
[TBL] [Abstract][Full Text] [Related]
6. Co-morbidity in older patients with COPD--its impact on health service utilisation and quality of life, a community study.
Yeo J; Karimova G; Bansal S
Age Ageing; 2006 Jan; 35(1):33-7. PubMed ID: 16364931
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.
Miravitlles M; Ferrer M; Pont A; Luis Viejo J; Fernando Masa J; Gabriel R; Jiménez-Ruiz CA; Villasante C; Fernández-Fau L; Sobradillo V
Respir Med; 2005 Aug; 99(8):985-95. PubMed ID: 15950139
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.
Lindberg A; Bjerg A; Rönmark E; Larsson LG; Lundbäck B
Respir Med; 2006 Feb; 100(2):264-72. PubMed ID: 15975774
[TBL] [Abstract][Full Text] [Related]
9. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study.
Montes de Oca M; Tálamo C; Perez-Padilla R; Jardim JR; Muiño A; Lopez MV; Valdivia G; Pertuzé J; Moreno D; Halbert RJ; Menezes AM;
Respir Med; 2008 May; 102(5):642-50. PubMed ID: 18314321
[TBL] [Abstract][Full Text] [Related]
10. Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study.
Maleki-Yazdi MR; Lewczuk CK; Haddon JM; Choudry N; Ryan N
COPD; 2007 Dec; 4(4):313-20. PubMed ID: 18027158
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities.
Miravitlles M; Soriano JB; García-Río F; Muñoz L; Duran-Tauleria E; Sanchez G; Sobradillo V; Ancochea J
Thorax; 2009 Oct; 64(10):863-8. PubMed ID: 19553233
[TBL] [Abstract][Full Text] [Related]
12. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
[TBL] [Abstract][Full Text] [Related]
13. Gender-associated differences in dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease.
Katsura H; Yamada K; Wakabayashi R; Kida K
Respirology; 2007 May; 12(3):427-32. PubMed ID: 17539850
[TBL] [Abstract][Full Text] [Related]
14. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort.
Johnston AK; Mannino DM; Hagan GW; Davis KJ; Kiri VA
Thorax; 2008 Jul; 63(7):599-605. PubMed ID: 18245145
[TBL] [Abstract][Full Text] [Related]
15. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
[TBL] [Abstract][Full Text] [Related]
16. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
[TBL] [Abstract][Full Text] [Related]
17. Impact of chronic obstructive pulmonary disease on respiratory status and quality of life in newly diagnosed patients with lung cancer.
Mohan A; Mohan C; Pathak AK; Pandey RM; Guleria R
Respirology; 2007 Mar; 12(2):240-7. PubMed ID: 17298457
[TBL] [Abstract][Full Text] [Related]
18. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs.
Foglio K; Bianchi L; Bruletti G; Porta R; Vitacca M; Balbi B; Ambrosino N
Respir Med; 2007 Sep; 101(9):1961-70. PubMed ID: 17531455
[TBL] [Abstract][Full Text] [Related]
19. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
Medbø A; Melbye H
Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
[TBL] [Abstract][Full Text] [Related]
20. What predicts change in pulmonary function and quality of life in asthma or COPD?
Hesselink AE; van der Windt DA; Penninx BW; Wijnhoven HA; Twisk JW; Bouter LM; van Eijk JT
J Asthma; 2006 Sep; 43(7):513-9. PubMed ID: 16939991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
